Optimising the design of phase II oncology trials: The importance of randomisation

Mark J. Ratain, Daniel J. Sargent

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Optimising the design of phase II oncology trials: The importance of randomisation'. Together they form a unique fingerprint.

Medicine & Life Sciences